IMPACT Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:IMPACT Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10673
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IMPACT Therapeutics Inc (IMPACT) is a developer of therapeutics to treat cancer and other life-threatening diseases. The company provides products such as microtubule inhibitors, PARP-1 inhibitors, and Hedgehog pathway inhibitors for oncology. Its PARP-1 inhibitor is an oral bioavailability; and IMP04297 is an efficacious in several animal cancer models. The company also develops IMP3138, a small molecular microtubule inhibitor clinical candidate with advantages in vitro and in vivo over paclitaxel. It also operates oncology drug discovery and several anticancer drug development projects. IMPACT is headquartered in Nanjing, China.

IMPACT Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Impact Therapeutics Raises USD30 Million in Series C Venture Financing 10
IMPACT Therapeutics Raises USD10 Million in Series B Financing 11
IMPACT Therapeutics Raises Funds through Series A Financing 12
IMPACT Therapeutics Inc – Key Competitors 13
IMPACT Therapeutics Inc – Key Employees 14
IMPACT Therapeutics Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IMPACT Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Impact Therapeutics Raises USD30 Million in Series C Venture Financing 10
IMPACT Therapeutics Raises USD10 Million in Series B Financing 11
IMPACT Therapeutics Raises Funds through Series A Financing 12
IMPACT Therapeutics Inc, Key Competitors 13
IMPACT Therapeutics Inc, Key Employees 14

List of Figures
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IMPACT Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[IMPACT Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IRadimed Corp (IRMD):企業の財務・戦略的SWOT分析
    Summary IRadimed Corp (IRadimed) is a medical device manufacturing company. The company is engaged in the manufacture and distribution of magnetic resonance imaging medical devices and related accessories and services. It's product portfolio includes non magentic IV infusion pumps, patient vital sig …
  • Parker Hannifin Corp (PH):医療機器:M&Aディール及び事業提携情報
    Summary Parker Hannifin Corp (Parker) is a manufacturer of motion and control technologies and systems. The company offers critical motion and control solutions, including fluid power systems, electromechanical controls and related components. Its products find use in various industries and applicat …
  • Dr. Reddy’s Research and Development BV-医療機器分野:企業M&A・提携分析
    Summary Dr. Reddy’s Research and Development BV (Dr. Reddy’s Research and Development), a subsidiary of Dr. Reddy's Laboratories Ltd is a drug formulation and manufacturing service provider that develops and manufactures improved injectable pharmaceuticals. The company offers services such as formul …
  • Oncopeptides AB (ONCO):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncopeptides AB (Oncopeptides) is a clinical development pharmaceutical company that offers development of oncology therapies to treat multiple myeloma. The company’s lead product candidate Ygalo (melflufen) is a peptidase potentiated cytotoxic drug and a potent anti-angiogenetic compound, a …
  • Premaitha Health Plc (NIPT):企業の財務・戦略的SWOT分析
    Premaitha Health Plc (NIPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • CymaBay Therapeutics Inc (CBAY):製薬・医療:M&Aディール及び事業提携情報
    Summary CymaBay Therapeutics Inc (CymaBay), formerly Metabolex Inc is a clinical-stage biopharmaceutical company that develops therapeutics to treat diabetes, orphan diseases and related metabolic disorders. The company’s pipeline products comprise Arhalofenate, an oral small molecule intended for t …
  • Hetero Drugs Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Hetero Drugs Ltd (Hetero) is a manufacturer of active pharmaceutical ingredients, intermediate chemicals and finished dosages. The company specializes in process chemistry, API manufacturing, formulation development, manufacturing and commercialization of bio-generics, and also offers custom …
  • OncoTherapy Science Inc (4564):企業の財務・戦略的SWOT分析
    Summary OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and d …
  • Panmure Gordon & Co Limited (PMR):企業の財務・戦略的SWOT分析
    Panmure Gordon & Co Limited (PMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • UCB Inc-製薬・医療分野:企業M&A・提携分析
    Summary UCB Inc (UCB), a subsidiary of UCB SA is a healthcare solutions provider that offers therapeutics. The company develops products with an emphasis on central nervous system and immunology therapeutic domains. Its products include cimzia, vimpat, keppra XR, neupro, tussionex pennkinetic, metad …
  • Grupo Aval Acciones Y Valores Sa:企業の戦略・SWOT・財務分析
    Grupo Aval Acciones Y Valores Sa - Strategy, SWOT and Corporate Finance Report Summary Grupo Aval Acciones Y Valores Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Gothaer Asigurari Reasigurari S.A.:企業の戦略・SWOT・財務情報
    Gothaer Asigurari Reasigurari S.A. - Strategy, SWOT and Corporate Finance Report Summary Gothaer Asigurari Reasigurari S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Telormedix SA-製薬・医療分野:企業M&A・提携分析
    Summary Telormedix SA (Telormedix) is a biopharmaceutical company. The company develops and provides immune drugs for the treatment of cancer and other infectious diseases. It offers products such as TMX-201, TMX-202 and vesimune (TMX-101). Its vesimune (TMX-101) provides treatment for superficial b …
  • Microsemi Corp:企業の戦略的SWOT分析
    Microsemi Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Voyager Therapeutics Inc (VYGR):企業の財務・戦略的SWOT分析
    Summary Voyager Therapeutics Inc (Voyager) is a clinical-stage gene therapy company that develops treatments for patients suffering from severe neurological diseases. The company provides treatment for adeno-associated virus gene therapy field by selecting, designing and manufacturing vectors. Its c …
  • CP Kelco:企業の戦略・SWOT・財務情報
    CP Kelco - Strategy, SWOT and Corporate Finance Report Summary CP Kelco - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Petroleos de Venezuela SA:企業の戦略的SWOT分析
    Petroleos de Venezuela SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • MicroPort Scientific Corp (853)-医療機器分野:企業M&A・提携分析
    Summary MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co Ltd is a medical device company that develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, el …
  • GV Gold:企業の戦略・SWOT・財務情報
    GV Gold - Strategy, SWOT and Corporate Finance Report Summary GV Gold - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • SI-Bone Inc (SIBN):医療機器:M&Aディール及び事業提携情報
    Summary SI-Bone Inc (SI-BONE) is a medical device company that develops, manufactures and distributes diagnosing and treating patients with SI joint disorders products and tools. The company offers medical devices for patients with low back issues, degenerative sacroiliitis, and SI joint disruptions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆